PD-L1 chimeric costimulatory receptor improves the efficacy of CAR-T cells for PD-L1-positive solid tumors and reduces toxicity in vivo.
Biomark Res. 2020 Nov 2;8(1):57. doi: 10.1186/s40364-020-00237-w.
Biomark Res. 2020.
PMID: 33292688
Free PMC article.